The Long Run with Luke Timmerman

← The Long Run with Luke Timmerman9. Sept. · 1 Std. 36 Min.

Ep209: Mathai Mammen on Developing Drugs Against Undruggable Targets

Ep209: Mathai Mammen on Developing Drugs Against Undruggable Targets9. Sept.1 Std. 36 Min.

Mathai Mammen, CEO of Cambridge, Mass.-based Parabilis Medicine, on developing alpha helical peptide molecules against hard targets of disease.